NIKINasdaqMeasuring & Controlling Devices, NECFiscal year ends December 31
Niki BioSolutions, Inc.
Financials through Q4 FY2025, quarter ended Dec 31, 2025Last filing: 20-F on Mar 27, 2026
$2.08+0.05 (+2.46%)
Close on Oct 19, 2026
- Market cap
- $16.66M
- P/E (TTM)
- –
- Dividend yield
- –
Community
Notes and questions about Niki BioSolutions from other investors
No posts about NIKI yet
Discussion opens with sign-in. Posts will be able to point at any number on these pages, so everyone sees exactly which figure is being discussed.